Cargando…

TFE3 gene rearrangement and protein expression contribute to a poor prognosis of renal cell carcinoma

BACKGROUND: TFE3-rearranged renal cell carcinoma (TFE3-rearranged RCC) is a type of kidney cancer with a low incidence, with no consensus about whether it has a worse prognosis than clear cell renal cell carcinoma (ccRCC). This study attempted to elucidate the impact of TFE3-rearranged RCC by analyz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Junyi, Tang, Zhuang, Zhang, Chengjunyu, Dong, Wen, Liu, Yeqing, Huang, Hao, Liu, Hao, Huang, Jian, Lin, Tianxin, Chen, Xu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196445/ https://www.ncbi.nlm.nih.gov/pubmed/37215783 http://dx.doi.org/10.1016/j.heliyon.2023.e16076

Ejemplares similares

TFE3-rearranged renal cell carcinoma with osseous metaplasia and indolent behaviour
por: Aldera, Alessandro Pietro, et al.
Publicado: (2022)

Xp11.2 Translocation Renal Cell Carcinoma With TFE3 Rearrangement: Distinct Morphological Features and Prognosis With Different Fusion Partners
por: Ge, Yan, et al.
Publicado: (2021)

MiT/TFE Family Renal Cell Carcinoma
por: Tang, Jinglong, et al.
Publicado: (2023)

Clinicopathological features and prognosis of TFE3-positive renal cell carcinoma
por: Dong, Xiang, et al.
Publicado: (2022)

TFE3-rearranged renal cell carcinoma with tumour thrombus in the ureter mimicking invasive transitional cell carcinoma
por: Chacko, Arman Z., et al.
Publicado: (2023)

TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms
por: Caliò, Anna, et al.
Publicado: (2022)

Elevated PTTG1 predicts poor prognosis in kidney renal clear cell carcinoma and correlates with immunity
por: Zhang, Xinyu, et al.
Publicado: (2023)

Case Reports of TFE3-Rearranged Renal Cell Carcinoma: FDG-PET Uptake Might Help Diagnosis
por: Murakami, Sho, et al.
Publicado: (2023)

The suitability of NONO-TFE3 dual-fusion FISH assay as a diagnostic tool for NONO-TFE3 renal cell carcinoma
por: Liu, Ning, et al.
Publicado: (2020)

Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinoma
por: Sun, Guangxi, et al.
Publicado: (2021)

Hepatic YAP1-TFE3 Rearranged Epithelioid Hemangioendothelioma
por: Lotfalla, Mira M., et al.
Publicado: (2019)

Hypoxia induces TFE3 expression in head and neck squamous cell carcinoma
por: Sun, Zhi-Jun, et al.
Publicado: (2016)

Malignant renal epithelioid angiomyolipoma with TFE3 gene amplification mimicking renal carcinoma
por: Wang, Haili, et al.
Publicado: (2018)

Lingual alveolar soft part sarcoma with absent TFE3 rearrangement
por: Alshahrani, Saeed, et al.
Publicado: (2020)

A Rare Partner of TFE3 in the Xp11 Translocation Renal Cell Carcinoma: Clinicopathological Analyses and Detection of MED15-TFE3 Fusion
por: Ye, Hong, et al.
Publicado: (2019)

NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma
por: Pei, Jianming, et al.
Publicado: (2019)

Case Report: Gastrointestinal PEComa With TFE3 Rearrangement Treated With Anti-VEGFR TKI Apatinib
por: Xu, Jiaming, et al.
Publicado: (2020)

Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis
por: Liu, Ning, et al.
Publicado: (2016)

PRCC-TFE3 dual-fusion FISH assay: A new method for identifying PRCC-TFE3 renal cell carcinoma in paraffin-embedded tissue
por: Xiong, Lei, et al.
Publicado: (2017)

Epithelioid hemangioendotheliomas with TFE3 gene translocations are compossible with CAMTA1 gene rearrangements
por: Lee, Seok Joo, et al.
Publicado: (2016)

NRF-1 directly regulates TFE3 and promotes the proliferation of renal cancer cells
por: Zhuang, Wenyuan, et al.
Publicado: (2021)

A safe and effective treatment combination of neoadjuvant therapy and surgical resection for metastatic TFE3-rearranged renal cell carcinoma:a case report
por: Yang, Haiyang, et al.
Publicado: (2023)

High CD204(+) tumor-infiltrating macrophage density predicts a poor prognosis in patients with urothelial cell carcinoma of the bladder
por: Wang, Bo, et al.
Publicado: (2015)

Emerging roles of TFE3 in metabolic regulation
por: Li, Xingyu, et al.
Publicado: (2023)

A Novel Lymphangiogenesis-Related Gene Signature can Predict Prognosis and Immunosuppressive Microenvironment in Patients with Clear Cell Renal Cell Carcinoma
por: Chen, Ke, et al.
Publicado: (2023)

Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation/TFE3 gene fusion renal cell carcinomas
por: Zhou, Jiale, et al.
Publicado: (2022)

Ultrasonographic Findings of Renal Cell Carcinomas Associated with Xp11.2 Translocation/TFE3 Gene Fusion
por: Ling, Wenwu, et al.
Publicado: (2017)

LncRNA SNHG17 Contributes to Proliferation, Migration, and Poor Prognosis of Hepatocellular Carcinoma
por: Luo, Yue, et al.
Publicado: (2021)

Sunitinib treatment promotes metastasis of drug-resistant renal cell carcinoma via TFE3 signaling pathway
por: Li, Luchao, et al.
Publicado: (2021)

CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinoma
por: Zheng, Hao, et al.
Publicado: (2017)

High expression of CD73 contributes to poor prognosis of clear-cell renal cell carcinoma by promoting cell proliferation and migration
por: Zhou, Yihong, et al.
Publicado: (2022)

Granular cell tumors overexpress TFE3 without gene rearrangement: Evaluation of immunohistochemistry and break-apart FISH in 45 cases
por: Liu, Yang, et al.
Publicado: (2019)

Multimodality imaging of Xp11.2 translocation/TFE3 gene fusion associated with renal cell carcinoma: a case report
por: Huang, Wenpeng, et al.
Publicado: (2023)

Modelling TFE renal cell carcinoma in mice reveals a critical role of WNT signaling
por: Calcagnì, Alessia, et al.
Publicado: (2016)

MiTF/TFE Translocation Renal Cell Carcinomas: From Clinical Entities to Molecular Insights
por: Simonaggio, Audrey, et al.
Publicado: (2022)

CDK4/6 regulate lysosome biogenesis through TFEB/TFE3
por: Yin, Qiuyuan, et al.
Publicado: (2020)

Alveolar soft part sarcoma of lung: report of a unique case with emphasis on diagnostic utility of molecular genetic analysis for TFE3 gene rearrangement and immunohistochemistry for TFE3 antigen expression
por: Zhao, Ming, et al.
Publicado: (2015)

Heterogeneous nuclear ribonucleoprotein K is associated with poor prognosis and regulates proliferation and apoptosis in bladder cancer
por: Chen, Xu, et al.
Publicado: (2016)

Emerging roles and regulation of MiT/TFE transcriptional factors
por: Yang, Min, et al.
Publicado: (2018)

Overexpression of SPHK1 associated with targeted therapy resistance in predicting poor prognosis in renal cell carcinoma
por: Bao, Ji-Ming, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kp5n0ugk7nb0884mu448sgg83h